STOCK TITAN

PTCT (NASDAQ: PTCT) files Rule 144 for 1,503-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A Rule 144 notice has been filed for the planned sale of 1,503 shares of common stock, with an aggregate market value of 116,458.15. The shares are to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an approximate sale date of 01/07/2026. The shares were acquired on 01/05/2026 through restricted stock vesting from the issuer as compensation.

As context, the filing lists 80,288,305 shares of common stock outstanding. The person named in the notice, Mark Boulding, has also sold common shares of the same issuer during the past three months in several transactions, each with disclosed dates, share amounts, and gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the PTCT Rule 144 filing disclose about planned stock sales?

The notice discloses an intent to sell 1,503 shares of common stock with an aggregate market value of 116,458.15, to be sold through Fidelity Brokerage Services LLC on NASDAQ around 01/07/2026.

How were the PTCT shares in this Rule 144 notice acquired?

The 1,503 common shares were acquired on 01/05/2026 via restricted stock vesting from the issuer, and the filing classifies the nature of payment as compensation.

How many PTCT shares are reported as outstanding in this Rule 144 filing?

The Rule 144 disclosure lists 80,288,305 shares of the issuer’s common stock as outstanding.

Who is the seller named in the recent PTCT Rule 144 notice?

The filing identifies Mark Boulding, with an address at 500 Warren Corporate Center Drive, Warren, NJ 07059, as the person for whose account the securities are to be sold.

What prior PTCT stock sales by the same person are disclosed in the last 3 months?

The notice lists several prior sales of common stock by Mark Boulding over the past three months, including transactions on 10/07/2025, 11/17/2025, 01/05/2026, and 01/06/2026, each with specific share amounts and gross proceeds.

What representation does the seller make in signing the PTCT Rule 144 form?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

5.44B
78.09M
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN